Cargando…

DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2

BACKGROUND: Recent studies highlight pseudogene derived long non-coding RNAs (lncRNAs) as key regulators of cancer biology. However, few of them have been well characterized in pancreatic cancer. Here, we aimed to identify the association between pseudogene derived lncRNA DUXAP8 and growth of pancre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lian, Yifan, Yang, Jiebin, Lian, Yikai, Xiao, Chuangxing, Hu, Xuezhen, Xu, Hongzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235391/ https://www.ncbi.nlm.nih.gov/pubmed/30367681 http://dx.doi.org/10.1186/s40880-018-0333-9

Ejemplares similares

Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes
por: Yang, Jiebin, et al.
Publicado: (2020)

The pseudogene derived from long non-coding RNA DUXAP10 promotes colorectal cancer cell growth through epigenetically silencing of p21 and PTEN
por: Lian, Yifan, et al.
Publicado: (2017)

A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer
por: Lian, Yifan, et al.
Publicado: (2018)

Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers
por: Chen, Jing, et al.
Publicado: (2019)

The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression
por: Ma, Hong-wei, et al.
Publicado: (2016)

Knockdown of pseudogene DUXAP8 expression in glioma suppresses tumor cell proliferation
por: Zhao, Xu, et al.
Publicado: (2020)

Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p
por: Liu, Yi, et al.
Publicado: (2021)

Downregulated DUXAP8 lncRNA impedes trophoblast cell proliferation and migration by epigenetically upregulating TFPI2 expression
por: Tang, Xiaotong, et al.
Publicado: (2023)

Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA
por: Scarola, Michele, et al.
Publicado: (2015)

The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer
por: Zhao, Junjie, et al.
Publicado: (2022)

The pseudogene DUXAP10 contributes to gefitinib resistance in NSCLC by repressing OAS2 expression: DUXAP10 contributes to gefitinib resistance by repressing OAS2
por: Ren, Shengnan, et al.
Publicado: (2022)

LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2
por: Guo, Mengjun, et al.
Publicado: (2022)

LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
por: Xu, Tianwei, et al.
Publicado: (2020)

LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis
por: Wang, Yongfeng, et al.
Publicado: (2022)

Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types
por: Vrba, Lukas, et al.
Publicado: (2018)

LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
por: Fei, Fan, et al.
Publicado: (2018)

lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1
por: Hu, Yu, et al.
Publicado: (2020)

A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics
por: Rapicavoli, Nicole A, et al.
Publicado: (2013)

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII
por: Shao, Mingjing, et al.
Publicado: (2017)

Retraction: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2021)

LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma
por: Huang, Shanshan, et al.
Publicado: (2021)

LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia
por: Zhai, Hong, et al.
Publicado: (2021)

Expression of Concern: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2020)

Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis
por: Liu, Yuenan, et al.
Publicado: (2022)

LncRNA H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy
por: Zhuo, Chuanjun, et al.
Publicado: (2016)

Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma
por: Yue, Chaosen, et al.
Publicado: (2019)

The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer
por: Wei, Chen-Chen, et al.
Publicado: (2016)

Pseudogene DUXAP8 Promotes Cell Proliferation and Migration of Hepatocellular Carcinoma by Sponging MiR-490-5p to Induce BUB1 Expression
por: Zhang, Haiping, et al.
Publicado: (2020)

FUS-dependent loading of SUV39H1 to OCT4 pseudogene-lncRNA programs a silencing complex with OCT4 promoter specificity
por: Scarola, Michele, et al.
Publicado: (2020)

LncRNA DUXAP9‐206 directly binds with Cbl‐b to augment EGFR signaling and promotes non‐small cell lung cancer progression
por: Zhu, Ting, et al.
Publicado: (2018)

Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de‐palmitoylation
por: Shi, Zhehao, et al.
Publicado: (2023)

Identifying Complex lncRNA/Pseudogene–miRNA–mRNA Crosstalk in Hormone-Dependent Cancers
por: Jayarathna, Dulari K., et al.
Publicado: (2021)

Epigenetic silencing of E‐cadherin gene induced by lncRNA MALAT‐1 in acute myeloid leukaemia
por: Huang, Jinlong, et al.
Publicado: (2022)

A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer
por: Lian, Yifan, et al.
Publicado: (2017)

LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis
por: Zhu, Hong-Yan, et al.
Publicado: (2021)

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway
por: Tan, Lei, et al.
Publicado: (2021)

Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway
por: Yang, Jing‐Jing, et al.
Publicado: (2020)

KLF5-Modulated lncRNA NEAT1 Contributes to Tumorigenesis by Acting as a Scaffold for BRG1 to Silence GADD45A in Gastric Cancer
por: Ma, Pei, et al.
Publicado: (2020)

Silencing of lncRNA KLF3‐AS1 represses cell growth in osteosarcoma via miR‐338‐3p/MEF2C axis
por: Chen, Chunfa, et al.
Publicado: (2022)

Pseudogenes and Liquid Phase Separation in Epigenetic Expression
por: Nsengimana, Bernard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v9lb8haj5n24skc7vqosm11bu1